We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.4%
3 Year Est. Return
+87.65%
5 Year Est. Return
10 Year Est. Return
AUM
$1.09B
AUM Growth
+$46.6M
Cap. Flow
-$32.7M
Cap. Flow %
-2.99%
Top 10 Hldgs %
37.4%
Holding
687
New
21
Increased
119
Reduced
192
Closed
27

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$8.61M
2
BEPC icon
Brookfield Renewable
BEPC
+$2.56M
3
CHWY icon
Chewy
CHWY
+$1.07M
4
ARE icon
Alexandria Real Estate Equities
ARE
+$534K
5
NKE icon
Nike
NKE
+$481K

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Healthcare 16.03%
3 Industrials 13%
4 Communication Services 12.61%
5 Consumer Discretionary 12.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
626
Fifth Third Bancorp
FITB
$51.3B
$2.74K ﹤0.01%
74
SPIP icon
627
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
$2.74K ﹤0.01%
107
NRDY icon
628
Nerdy
NRDY
$108M
$2.66K ﹤0.01%
913
MAT icon
629
Mattel
MAT
$4.47B
$2.63K ﹤0.01%
133
EG icon
630
Everest Group
EG
$15.6B
$2.63K ﹤0.01%
7
SNDX icon
631
Syndax Pharmaceuticals
SNDX
$1.7B
$2.55K ﹤0.01%
+107
New +$2.39K
KURA icon
632
Kura Oncology
KURA
$793M
$2.45K ﹤0.01%
115
TER icon
633
Teradyne
TER
$50B
$2.26K ﹤0.01%
+20
New +$2.08K
RPAY icon
634
Repay Holdings
RPAY
$335M
$2.25K ﹤0.01%
205
AVPT icon
635
AvePoint
AVPT
$2.76B
$2.25K ﹤0.01%
284
NARI
636
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.21K ﹤0.01%
46
CGEM icon
637
Cullinan Oncology
CGEM
$1.06B
$2.17K ﹤0.01%
127
CGON icon
638
CG Oncology
CGON
$6.1B
$2.15K ﹤0.01%
+49
New +$2K
BRDG
639
DELISTED
Bridge Investment Group
BRDG
$1.85K ﹤0.01%
270
RVNC
640
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.79K ﹤0.01%
364
CRS icon
641
Carpenter Technology
CRS
$26.4B
$1.79K ﹤0.01%
25
GPCR icon
642
Structure Therapeutics
GPCR
$3.37B
$1.76K ﹤0.01%
41
APP icon
643
Applovin
APP
$134B
$1.75K ﹤0.01%
+25
New +$1.32K
BSY icon
644
Bentley Systems
BSY
$11.2B
$1.75K ﹤0.01%
34
-30
-47% -$1.51K
LUNG icon
645
Pulmonx
LUNG
$52.8M
$1.55K ﹤0.01%
167
FLNA
646
Filana Therapeutics
FLNA
$42M
$1.52K ﹤0.01%
75
KYTX icon
647
Kyverna Therapeutics
KYTX
$430M
$1.49K ﹤0.01%
+60
New +$1.67K
NYC
648
American Strategic Investment Co
NYC
$30.4M
$1.42K ﹤0.01%
224
CYRX icon
649
CryoPort
CYRX
$753M
$1.24K ﹤0.01%
70
XPEV icon
650
XPeng
XPEV
$12.5B
$1.15K ﹤0.01%
150

Similar funds

Washington Trust Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Washington Trust Advisors held 687 positions worth $1.09B, up 4.5% from $1.04B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Washington Trust Advisors's Q1 2024 filing shows 21 new, 119 increased, 192 reduced and 27 closed positions. Its largest new stake was iShares Core 80/20 Aggressive Allocation ETF: 691 shares worth $50.8K. The largest sale was Splunk Inc, an estimated $11.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Washington Trust Advisors's largest Q1 2024 buy was iShares Core 80/20 Aggressive Allocation ETF: 691 shares worth $50.8K.
  • Washington Trust Advisors added most to Snowflake in Q1 2024, an estimated $8.61M increase.
  • Washington Trust Advisors's biggest Q1 2024 reduction was Palo Alto Networks, cutting an estimated $4.97M.
  • Washington Trust Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $11.7M.
  • Washington Trust Advisors's ten largest holdings make up 37% of its $1.09B portfolio in Q1 2024.
  • Washington Trust Advisors opened 21 new positions and closed 27 in Q1 2024.
  • Washington Trust Advisors's portfolio value rose 4.5% quarter-over-quarter to $1.09B.

Based on Washington Trust Advisors's 13F filing for Q1 2024, filed 7 May 2024.